3349 pSFFV-neo Bcl-2 Citations (1)

Originally described in: BCL-2 is phosphorylated and inactivated by an ASK1/Jun N-terminal protein kinase pathway normally activated at G(2)/M.
Yamamoto K, Ichijo H, Korsmeyer SJ Mol Cell Biol 1999 Dec;19(12):8469-78. PubMed

---

Articles Citing 3349 pSFFV-neo Bcl-2

Articles
Retinoic acid synergizes ATO-mediated cytotoxicity by precluding Nrf2 activity in AML cells. Valenzuela M, Glorieux C, Stockis J, Sid B, Sandoval JM, Felipe KB, Kviecinski MR, Verrax J, Buc Calderon P. Br J Cancer. 2014 Aug 26;111(5):874-82. doi: 10.1038/bjc.2014.380. Epub 2014 Jul 8. PubMed

If you have published an article using this material, please email us at to have your article added to this page.